Oramed Pharmaceuticals Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	2016 - 2020
Period Ending	Jan '26 Jan 29, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Aug '21 Aug 31, 2021	2016 - 2020
Market Capitalization	428	355	336	1,655	1,692	2,051	Upgrade
Market Cap Growth	23.06%	5.88%	-79.72%	-2.19%	-17.53%	477.70%	Upgrade
Enterprise Value	10	-167	-33	1,094	1,382	1,810	Upgrade
Last Close Price	10.64	7.92	7.63	36.13	37.96	58.90	Upgrade
PE Ratio	2.95	-	16.87	-	-	-	Upgrade
PS Ratio	64.66	-	69.54	174.08	200.54	236.73	Upgrade
PB Ratio	0.64	0.67	0.57	3.11	3.26	5.49	Upgrade
P/TBV Ratio	0.64	0.67	0.57	3.10	3.27	5.53	Upgrade
EV/Sales Ratio	1.67	-	-	115.15	163.83	208.87	Upgrade
EV/FCF Ratio	-0.29	-	-	-	-	-	Upgrade
Debt / Equity Ratio	0.00	0.00	0.32	0.01	0.00	0.01	Upgrade
Asset Turnover	0.01	-	0.01	0.02	-	0.03	Upgrade
Quick Ratio	22.08	24.97	3.05	27.10	19.85	14.10	Upgrade
Current Ratio	22.25	25.19	3.06	27.34	20.08	14.27	Upgrade
Return on Equity (ROE)	24.48%	-12.39%	3.24%	-23.77%	-	-30.78%	Upgrade
Return on Assets (ROA)	-4.22%	-4.25%	-5.16%	-14.95%	-	-17.54%	Upgrade
Return on Capital Employed (ROCE)	-6.10%	-8.50%	-9.40%	-26.00%	-21.70%	-20.00%	Upgrade
Earnings Yield	33.91%	-19.54%	5.93%	-7.77%	-6.44%	-3.48%	Upgrade
FCF Yield	-8.20%	-8.64%	-11.32%	-6.04%	-6.14%	-3.37%	Upgrade
Buyback Yield / Dilution	-3.29%	-0.65%	-4.02%	-5.08%	-30.36%	-16.71%	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.